These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 983667)

  • 1. [Polycardiographic evaluation of cardiotoxic effects of rubidomycin in patients with acute leukemia].
    Wodniecki J; Prochaczek F; Holowiecki J; Stella B
    Acta Haematol Pol; 1976; 7(3):195-8. PubMed ID: 983667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiotoxic effect of anthracycline antibiotics].
    Jovanović I; Ceranić LJ; Simeunović S; Cvetković P
    Bilt Hematol Transfuz; 1983; 11(2-3):51-7. PubMed ID: 6680300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in myocardial function in patients with acute leukemias under the influence of rubomycin].
    Bessmel'tsev SS; Abdulkadyrov KM
    Ter Arkh; 1994; 66(11):80-4. PubMed ID: 7900029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrocardiographic changes in patients with acute leukoses treated with rubidomycin or adriamycin at the Internal Clinic A].
    Avramović D; Stefanović S; Konecni J; Kovacević M; Ristić M
    Bilt Hematol Transfuz; 1976; 4(1-2):105-8. PubMed ID: 942366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute heart failure after a moderate dose of rubidomycin].
    Baledent M; Messerschmitt J; Bens JL; Quiret JC; Faille N
    Sem Hop; 1972 Feb; 48(7):507-10. PubMed ID: 4338408
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiac toxicity of rubidomycin. Apropos of 2 cases].
    Laine JL; Julienne O; Leroy J; Lamagnère JP; Laugier J; Desbuquois G
    Pediatrie; 1973 Mar; 28(2):201-10. PubMed ID: 4725976
    [No Abstract]   [Full Text] [Related]  

  • 8. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].
    Bauters F; Plouvier B; Breviere G; Goudemand M
    Sem Hop; 1975 Jun; 51(28):1949-57. PubMed ID: 180611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attemp at treatment of acute leukemia and Hodgkin's disease by rubidomycin or daunomycin alone or combined].
    Mathe G; Amiel JL; Hayat M; Schwarzenberg L; Schenider M; Cattan A; Schlumberger JR; Ceoara B
    Sem Hop; 1967 Jul; 43(32):2108-14. PubMed ID: 4328374
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sudden death in leukemic patients treated with doxorubicin].
    Lacasse Y; Bolduc P
    Can J Cardiol; 1992; 8(1):53-6. PubMed ID: 1617512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case].
    Fontaine JL; Bonnet-Gajdos M; Mougenot B
    Arch Fr Pediatr; 1974; 31(7):697-704. PubMed ID: 4531839
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for development of daunorubicin cardiotoxicity.
    Von Hoff DD; Layard M
    Cancer Treat Rep; 1981; 65 Suppl 4():19-23. PubMed ID: 7049377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of cardiotoxic effect of rubidomycin under clinical conditions].
    Eichelkraut A; Orłowska-Westwood B; Polakowski P
    Pol Tyg Lek; 1981 May; 36(19):657-9. PubMed ID: 6943517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroleukaemia and daunorubicin-induced cardiotoxicity in a young boy.
    Malhotra OP; Talwar KK; Chopra P; Kumar R
    Br J Clin Pract; 1990 Dec; 44(12):633-4. PubMed ID: 2102164
    [No Abstract]   [Full Text] [Related]  

  • 17. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
    Peterson BA; Bloomfield CD; Theologides A; Kennedy BJ
    Cancer Treat Rep; 1981; 65 Suppl 4():29-33. PubMed ID: 6955011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conbined treatment with rubidomycin and vincristine in acute leukemia in children].
    Gerwelowa H; Radwańska U; Michalewska D; Rafińska J
    Pediatr Pol; 1972; 47(5):573-9. PubMed ID: 5028799
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.
    Daghestani AN; Arlin ZA; Leyland-Jones B; Gee TS; Kempin SJ; Mertelsmann R; Budman D; Schulman P; Baratz R; Williams L
    Cancer Res; 1985 Mar; 45(3):1408-12. PubMed ID: 3855696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia.
    Pui CH; de Graaf SS; Dow LW; Rodman JH; Evans WE; Alpert BS; Murphy SB
    Cancer Res; 1988 Sep; 48(18):5348-52. PubMed ID: 3165708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.